08.22.2023 - By PeerVoice
Visit https://www.peervoice.com/FZR860 to view the entire programme with slides. After completing “Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?”, participants will be able to: Identify the current place in therapy for GLP-1 receptor agonists (RAs) within guideline-recommended treatment algorithms for type 2 diabetes mellitus (T2DM); Evaluate current efficacy and safety data related to the effects of GLP-1 RAs on glycaemia, cardiometabolic risk, and weight in patients with T2DM; and Identify patients with T2DM who would benefit from incorporation of a GLP-1 RA into their overall treatment plan.